BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21769957)

  • 1. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
    Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
    Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells.
    Chen W; Xiao BK; Liu JP; Chen SM; Tao ZZ
    Cancer Sci; 2010 Aug; 101(8):1769-76. PubMed ID: 20545697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.
    Venturini L; Daidone MG; Motta R; Cimino-Reale G; Hoare SF; Gronchi A; Folini M; Keith WN; Zaffaroni N
    Neuro Oncol; 2012 Jun; 14(6):736-44. PubMed ID: 22516689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
    Mangosh TL; Grabowska MM; Taylor DJ
    Prostate; 2021 Nov; 81(15):1235-1251. PubMed ID: 34492133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
    Costa A; Daidone MG; Daprai L; Villa R; Cantù S; Pilotti S; Mariani L; Gronchi A; Henson JD; Reddel RR; Zaffaroni N
    Cancer Res; 2006 Sep; 66(17):8918-24. PubMed ID: 16951210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma.
    Omori Y; Nakayama F; Li D; Kanemitsu K; Semba S; Ito A; Yokozaki H
    Cancer Sci; 2009 Mar; 100(3):413-8. PubMed ID: 19154407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative lengthening of telomeres in mammalian cells.
    Henson JD; Neumann AA; Yeager TR; Reddel RR
    Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALT-associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas.
    Venturini L; Erdas R; Costa A; Gronchi A; Pilotti S; Zaffaroni N; Daidone M
    J Pathol; 2008 Mar; 214(4):410-4. PubMed ID: 18085522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere maintenance by telomerase and by recombination can coexist in human cells.
    Cerone MA; Londono-Vallejo JA; Bacchetti S
    Hum Mol Genet; 2001 Sep; 10(18):1945-52. PubMed ID: 11555631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms of telomere maintenance exist in liposarcomas.
    Johnson JE; Varkonyi RJ; Schwalm J; Cragle R; Klein-Szanto A; Patchefsky A; Cukierman E; von Mehren M; Broccoli D
    Clin Cancer Res; 2005 Aug; 11(15):5347-55. PubMed ID: 16061847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
    Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
    Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.